Lipocine Inc. (LPCN) Ownership
LPCN ownership summary
as of October 18, 2026- Institutions
- 36.2% of shares outstanding
- Insiders
- 4.96% of shares outstanding
- Shares outstanding
- 8.2M
- Float
- 6.5M shares available to trade
- Short interest
- 1.21% 98K shares short
- Days to cover
- 2.95 short interest down 1.6% vs prior month
- Institutions 36.19%
- Insiders 4.96%
- Other investors 58.85%
LPCN top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Squadron Capital Management LLC | 9.82% | 810K | $1.3M | +360,000 (+80.0%) | June 30, 2026 |
| 2 | Ikarian Capital, LLC | 6.17% | 509K | $793,347 | — | June 30, 2026 |
| 3 | Eversept Partners, LP | 3.58% | 295K | $460,183 | — | June 30, 2026 |
| 4 | Vanguard Capital Management, LLC | 2.80% | 231K | $360,084 | +30,155 (+15.0%) | June 30, 2026 |
| 5 | Acadian Asset Management LLC | 2.07% | 170K | $265,851 | +170,417 (0.0%) | June 30, 2026 |
| 6 | BOOTHBAY FUND MANAGEMENT, LLC | 1.70% | 140K | $219,160 | — | June 30, 2026 |
| 7 | Jane Street Group LLC | 1.16% | 95K | $148,554 | +75,200 (+375.5%) | June 30, 2026 |
| 8 | BlackRock Inc | 1.08% | 89K | $139,264 | — | June 30, 2026 |
| 9 | Two Sigma Investments LLC | 1.03% | 85K | $132,424 | +51,137 (+151.5%) | June 30, 2026 |
| 10 | Citadel Advisors Llc | 0.99% | 81K | $126,705 | +52,133 (+179.2%) | June 30, 2026 |
| 11 | Seven Fleet Capital Management LP | 0.96% | 79K | $122,994 | −46,100 (−36.9%) | June 30, 2026 |
| 12 | Geode Capital Management, LLC | 0.90% | 74K | $116,184 | +11,342 (+18.0%) | June 30, 2026 |
| 13 | Renaissance Technologies Corp | 0.84% | 69K | $107,966 | +30,712 (+79.8%) | June 30, 2026 |
| 14 | Vanguard Fiduciary Trust Co | 0.66% | 55K | $85,081 | +22,126 (+68.3%) | June 30, 2026 |
| 15 | Dimensional Fund Advisors, Inc. | 0.45% | 37K | $57,369 | +17,653 (+92.3%) | June 30, 2026 |
| 16 | HRT FINANCIAL LLC | 0.35% | 29K | $45,611 | +29,238 (0.0%) | June 30, 2026 |
| 17 | Susquehanna International Group, LLP | 0.31% | 25K | $39,587 | +468 (+1.9%) | June 30, 2026 |
| 18 | State Street Corp | 0.27% | 22K | $34,955 | — | June 30, 2026 |
| 19 | GSA Capital Partners LLP | 0.23% | 19K | $29,119 | +18,666 (0.0%) | June 30, 2026 |
| 20 | Birchview Capital, LP | 0.20% | 17K | $26,071 | −95,074 (−85.0%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 13 holders added 869K shares and 2 cut 141K.
LPCN top mutual fund and ETF holders
16 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Vanguard MStar Total Stk Mkt Idx Invest | 1.73% | 143K | $222,726 | — | August 31, 2026 |
| 2 | Fidelity Extended Market Index | 0.53% | 44K | $67,880 | −234 (−0.5%) | August 31, 2026 |
| 3 | Fidelity Total Market Index | 0.11% | 8,688 | $13,553 | — | August 31, 2026 |
| 4 | Fidelity Series Total Market Index | 0.10% | 8,290 | $12,932 | — | August 31, 2026 |
| 5 | DFA US Sustainability Core 1 | 0.07% | 6,181 | $9,642 | — | August 31, 2026 |
| 6 | Dimensional US Small Cap ETF | 0.07% | 6,038 | $9,419 | — | September 30, 2026 |
| 7 | Dimensional US Sustainability Core 1 ETF | 0.06% | 5,180 | $8,081 | — | September 30, 2026 |
| 8 | Dimensional US Core Equity 1 ETF | 0.06% | 5,116 | $7,981 | — | September 24, 2026 |
| 9 | DFA US Micro Cap I | 0.06% | 5,040 | $7,862 | — | August 31, 2026 |
| 10 | Dimensional US Core Equity 2 ETF | 0.06% | 4,760 | $7,426 | — | September 30, 2026 |
| 11 | DFA US Vector Equity Class F | 0.04% | 3,500 | $5,460 | — | July 31, 2026 |
| 12 | Schwab Total Stock Market Index | 0.04% | 2,942 | $4,590 | — | August 31, 2026 |
| 13 | DFA US Vector Equity I | 0.03% | 2,156 | $3,363 | — | August 31, 2026 |
| 14 | Fidelity Nasdaq Composite Index | 0.02% | 1,748 | $2,727 | — | August 31, 2026 |
| 15 | Vanguard U.S. Eq Idx £ Acc | 0.02% | 1,691 | $2,638 | — | August 31, 2026 |
| 16 | DFA US Core Equity Class F | 0.01% | 1,222 | $1,906 | — | July 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
LPCN insider transactions
latest 4| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-04-07 | John W Higuchi | Buy | $2.03 | 40,000 | $81,200 |
| 2026-04-06 | John W Higuchi | Buy | $2.05 | 123,000 | $252,150 |
| 2026-04-06 | Mahesh V Patel | Buy | $2.03 | 25,000 | $50,750 |
| 2026-04-02 | Mahesh V Patel | Buy | $2.02 | 25,000 | $50,500 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
LPCN shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns LPCN
Institutional investors own 36.2% of Lipocine's shares and insiders 4.96%. The largest holder is Squadron Capital Management LLC with 9.82% of the shares (810K), as of June 30, 2026. Among the top 20 institutions, 13 added shares and 2 reduced their stake in the latest filings. Short interest is 1.21% of the float, or 2.95 days of average trading volume. The share count rose 658.5% since 2014.
Related: LPCN analyst forecast, LPCN key metrics. See the LPCN stock overview for the latest quote and news.
LPCN ownership FAQ
Who owns the most Lipocine stock?
The largest shareholders of Lipocine are Squadron Capital Management LLC (9.82%), Ikarian Capital, LLC (6.17%), Eversept Partners, LP (3.58%), Vanguard Capital Management, LLC (2.80%), Acadian Asset Management LLC (2.07%).
What percentage of Lipocine is owned by institutions?
Institutions hold 36.2% of Lipocine's shares outstanding; insiders hold 4.96%.
Which funds own Lipocine?
The largest fund holders of Lipocine are Vanguard MStar Total Stk Mkt Idx Invest (1.73%), Fidelity Extended Market Index (0.53%), Fidelity Total Market Index (0.11%), Fidelity Series Total Market Index (0.10%), DFA US Sustainability Core 1 (0.07%).
What is Lipocine's short interest?
98K shares of Lipocine were sold short, 1.21% of the float; at the average daily volume it would take 2.95 days to cover.
Are insiders buying or selling Lipocine?
Of the latest 4 reported insider transactions in Lipocine (since April 2, 2026), 4 were purchases and 0 were sales.
How many shares of Lipocine are outstanding?
Lipocine has 8.2M shares outstanding, of which 6.5M are in the public float.